TY - JOUR
T1 - Attenuation of Myelosuppression with Lithium
AU - Catane, R.
AU - Kaufman, J.
AU - Mittelman, A.
AU - Murphy, G. P.
PY - 1977/8/25
Y1 - 1977/8/25
N2 - To the Editor: Lithium causes granulocytosis by enhancing the production of colony-stimulating activity.1 Although in previous studies Tisman2 and Greco et al.3 suggested that patients receiving repeated courses of combination chemotherapy had less leukopenia with the addition of lithium carbonate, no randomized studies have been described. Ten patients with advanced hormone-resistant prostatic cancer treated with estramustine phosphate, 600 mg per square meter daily, and semustine (methyl-CCNU), 150 mg per square meter on the first day, were randomized to receive lithium carbonate or placebo. The first patients received 300 mg three times per day; later, the dose was reduced because of. No extract is available for articles shorter than 400 words.
AB - To the Editor: Lithium causes granulocytosis by enhancing the production of colony-stimulating activity.1 Although in previous studies Tisman2 and Greco et al.3 suggested that patients receiving repeated courses of combination chemotherapy had less leukopenia with the addition of lithium carbonate, no randomized studies have been described. Ten patients with advanced hormone-resistant prostatic cancer treated with estramustine phosphate, 600 mg per square meter daily, and semustine (methyl-CCNU), 150 mg per square meter on the first day, were randomized to receive lithium carbonate or placebo. The first patients received 300 mg three times per day; later, the dose was reduced because of. No extract is available for articles shorter than 400 words.
UR - http://www.scopus.com/inward/record.url?scp=0017622844&partnerID=8YFLogxK
U2 - 10.1056/NEJM197708252970819
DO - 10.1056/NEJM197708252970819
M3 - מזכר
AN - SCOPUS:0017622844
VL - 297
SP - 452
EP - 453
JO - New England Journal of Medicine
JF - New England Journal of Medicine
SN - 0028-4793
IS - 8
ER -